Shockwave Medical's IVL Compared to PTA in DISRUPT PAD III at 2 Years
May 19, 2022—Shockwave Medical, Inc. announced long-term data from the DISRUPT PAD III trial evaluating the company’s intravascular lithot
Source: evtoday.com
Stay updated with breaking news from Gray Is Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
May 19, 2022—Shockwave Medical, Inc. announced long-term data from the DISRUPT PAD III trial evaluating the company’s intravascular lithot